Literature DB >> 32981768

Medical, Nonmedical, and Illegal Stimulant Use by Sexual Identity and Gender.

Morgan M Philbin1, Emily R Greene2, Silvia S Martins2, Natalie J LaBossier3, Pia M Mauro2.   

Abstract

INTRODUCTION: Major knowledge gaps regarding medical and nonmedical prescription stimulant use and illegal stimulant use (i.e., cocaine/crack/methamphetamine) by sexual identity and gender have implications for individuals' health and well-being. This study improves stimulant use measurement by differentiating the type of stimulant use and focusing on lesbian, gay, and bisexual subpopulations.
METHODS: Data were pooled for adults in the 2015-2017 National Survey on Drug Use and Health (n=126,463; analyzed in 2019). Gender-stratified logistic regression models examined associations between sexual identity and past-year illegal stimulant use. Gender-stratified multinomial logistic regression models estimated odds of (1) medical use only versus no past-year prescription stimulant use, (2) any nonmedical stimulant use versus no past-year use, and (3) any nonmedical stimulant use versus medical use only.
RESULTS: Illegal stimulant use varied by sexual identity (men: gay, 9.2%; bisexual, 7.5%; heterosexual, 3.2%; women: gay/lesbian, 3.2%; bisexual, 7.8%; heterosexual, 1.5%), as did nonmedical prescription stimulant use. Relative to same-gender heterosexuals, gay (AOR=2.61, 95% CI=2.00, 3.40) and bisexual (AOR=1.70, 95% CI=1.24, 2.33) men had higher odds of past-year illegal stimulant use, as did gay/lesbian (AOR=1.63, 95% CI=1.16, 2.28) and bisexual (AOR=2.70, 95% CI=2.23, 3.26) women. Sexual minorities reported higher odds of nonmedical prescription stimulant use than heterosexuals. Any nonmedical prescription opioid use was reported by 26.4% of people who reported nonmedical stimulant use and 27.0% of people who reported illegal stimulant use.
CONCLUSIONS: Lesbian, gay, and bisexual individuals had a higher prevalence of stimulant use than their heterosexual counterparts. This has important implications for health disparities, especially given the high levels of polysubstance use. Taking a multilevel approach is crucial to reduce stimulant-related harms for lesbian, gay, and bisexual individuals.
Copyright © 2020 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32981768      PMCID: PMC7577928          DOI: 10.1016/j.amepre.2020.05.025

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  59 in total

1.  The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study.

Authors:  Michael W Plankey; David G Ostrow; Ron Stall; Christopher Cox; Xiuhong Li; James A Peck; Lisa P Jacobson
Journal:  J Acquir Immune Defic Syndr       Date:  2007-05-01       Impact factor: 3.731

Review 2.  Recent Trends in Stimulant Usage.

Authors:  Daniel J Safer
Journal:  J Atten Disord       Date:  2015-10-20       Impact factor: 3.256

3.  Substance use of lesbian, gay, bisexual and heterosexual college students.

Authors:  Dianne L Kerr; Kele Ding; Julie Chaya
Journal:  Am J Health Behav       Date:  2014-11

4.  Structural stigma and sexual orientation disparities in adolescent drug use.

Authors:  Mark L Hatzenbuehler; Hee-Jin Jun; Heather L Corliss; S Bryn Austin
Journal:  Addict Behav       Date:  2015-02-27       Impact factor: 3.913

5.  Rate of Fentanyl Positivity Among Urine Drug Test Results Positive for Cocaine or Methamphetamine.

Authors:  Leah LaRue; Robert K Twillman; Eric Dawson; Penn Whitley; Melissa A Frasco; Angela Huskey; Maria G Guevara
Journal:  JAMA Netw Open       Date:  2019-04-05

6.  Prevalence and patterns of smoking, alcohol use, and illicit drug use in young men who have sex with men.

Authors:  Michael E Newcomb; Daniel T Ryan; George J Greene; Robert Garofalo; Brian Mustanski
Journal:  Drug Alcohol Depend       Date:  2014-05-17       Impact factor: 4.492

7.  Nonmedical use of prescription drugs and HIV risk behavior in gay and bisexual men.

Authors:  Eric G Benotsch; Aaron M Martin; Stephen Koester; Anna Cejka; Diana Luckman
Journal:  Sex Transm Dis       Date:  2011-02       Impact factor: 2.830

8.  Lesbian, Gay, and Bisexual Adolescents: Population Estimate and Prevalence of Health Behaviors.

Authors:  Stephanie Zaza; Laura Kann; Lisa C Barrios
Journal:  JAMA       Date:  2016-12-13       Impact factor: 56.272

9.  Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.

Authors:  Brooke S G Molina; Stephen P Hinshaw; L Eugene Arnold; James M Swanson; William E Pelham; Lily Hechtman; Betsy Hoza; Jeffery N Epstein; Timothy Wigal; Howard B Abikoff; Laurence L Greenhill; Peter S Jensen; Karen C Wells; Benedetto Vitiello; Robert D Gibbons; Andrea Howard; Patricia R Houck; Kwan Hur; Bo Lu; Sue Marcus
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-02-08       Impact factor: 8.829

10.  Nonmedical use of prescription ADHD stimulants and preexisting patterns of drug abuse.

Authors:  Christine T Sweeney; Mark A Sembower; Michelle D Ertischek; Saul Shiffman; Sidney H Schnoll
Journal:  J Addict Dis       Date:  2013
View more
  7 in total

1.  Sexual Orientation and Age of First Drug Use Among Adults in the United States.

Authors:  İbrahim Sönmez; Joseph J Palamar
Journal:  Subst Use Misuse       Date:  2022-05-25       Impact factor: 2.362

2.  Substance Use, Health, and Adverse Life Events amongst Amphetamine-Type Stimulant Users in North East England: A Cross-Sectional Study.

Authors:  Emma Audrey Adams; Liam Spencer; Michelle Addison; William McGovern; Hayley Alderson; Mark Adley; Ruth McGovern; Eilish Gilvarry; Eileen Kaner; Amy O'Donnell
Journal:  Int J Environ Res Public Health       Date:  2022-06-07       Impact factor: 4.614

3.  Barriers and Facilitators to HIV Pre-Exposure Prophylaxis Uptake Among Men Who have Sex with Men Who Use Stimulants: A Qualitative Study.

Authors:  Adam Viera; Jacob J van den Berg; Collette D Sosnowy; Nikita A Mehta; E Jennifer Edelman; Trace Kershaw; Philip A Chan
Journal:  AIDS Behav       Date:  2022-03-18

4.  Racial/Ethnic and Geographic Trends in Combined Stimulant/Opioid Overdoses, 2007-2019.

Authors:  Tarlise Townsend; David Kline; Ariadne Rivera-Aguirre; Amanda M Bunting; Pia M Mauro; Brandon D L Marshall; Silvia S Martins; Magdalena Cerdá
Journal:  Am J Epidemiol       Date:  2022-03-24       Impact factor: 5.363

5.  Substance use treatment partially mitigates association between methamphetamine use and STI risk: findings from the NSDUH cohort.

Authors:  Jessica P Sherman; Christina Dyar; Ethan Morgan
Journal:  Sex Transm Infect       Date:  2021-05-05       Impact factor: 4.199

6.  Substance Use Treatment Engagement among Men Who Have Sex with Men Who Use Stimulants in the Northeastern United States.

Authors:  Adam Viera; Collette D Sosnowy; Jacob J van den Berg; Nikita A Mehta; E Jennifer Edelman; Trace Kershaw; Philip A Chan
Journal:  Subst Use Misuse       Date:  2022-01-22       Impact factor: 2.362

7.  Disparities in substance use disorder treatment use and perceived need by sexual identity and gender among adults in the United States.

Authors:  Anna Krasnova; José E Diaz; Morgan M Philbin; Pia M Mauro
Journal:  Drug Alcohol Depend       Date:  2021-06-24       Impact factor: 4.852

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.